IBDEI0I3 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8375,0)
 ;;=96366^^36^444^4^^^^1
 ;;^UTILITY(U,$J,358.3,8375,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8375,1,2,0)
 ;;=2^IV Infusion,Ea Addl Hr
 ;;^UTILITY(U,$J,358.3,8375,1,4,0)
 ;;=4^96366
 ;;^UTILITY(U,$J,358.3,8376,0)
 ;;=96360^^36^444^5^^^^1
 ;;^UTILITY(U,$J,358.3,8376,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8376,1,2,0)
 ;;=2^IV INF,HYDRATION,INIT 31-60MIN
 ;;^UTILITY(U,$J,358.3,8376,1,4,0)
 ;;=4^96360
 ;;^UTILITY(U,$J,358.3,8377,0)
 ;;=96361^^36^444^6^^^^1
 ;;^UTILITY(U,$J,358.3,8377,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8377,1,2,0)
 ;;=2^IV INF,HYDRATION,EA ADDL HR
 ;;^UTILITY(U,$J,358.3,8377,1,4,0)
 ;;=4^96361
 ;;^UTILITY(U,$J,358.3,8378,0)
 ;;=96374^^36^444^2^^^^1
 ;;^UTILITY(U,$J,358.3,8378,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8378,1,2,0)
 ;;=2^THER/PROPH/DIAG INJ IV PUSH
 ;;^UTILITY(U,$J,358.3,8378,1,4,0)
 ;;=4^96374
 ;;^UTILITY(U,$J,358.3,8379,0)
 ;;=99071^^36^445^5^^^^1
 ;;^UTILITY(U,$J,358.3,8379,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8379,1,2,0)
 ;;=2^PATIENT EDUCATION MATERIALS
 ;;^UTILITY(U,$J,358.3,8379,1,4,0)
 ;;=4^99071
 ;;^UTILITY(U,$J,358.3,8380,0)
 ;;=99078^^36^445^4^^^^1
 ;;^UTILITY(U,$J,358.3,8380,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8380,1,2,0)
 ;;=2^GROUP HEALTH EDUCATION
 ;;^UTILITY(U,$J,358.3,8380,1,4,0)
 ;;=4^99078
 ;;^UTILITY(U,$J,358.3,8381,0)
 ;;=99354^^36^445^6^^^^1
 ;;^UTILITY(U,$J,358.3,8381,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8381,1,2,0)
 ;;=2^PROLONGED OTPT SVC > 30 MIN
 ;;^UTILITY(U,$J,358.3,8381,1,4,0)
 ;;=4^99354
 ;;^UTILITY(U,$J,358.3,8382,0)
 ;;=99355^^36^445^7^^^^1
 ;;^UTILITY(U,$J,358.3,8382,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8382,1,2,0)
 ;;=2^PROLONG OTPT SVC,EA ADDL 30 MIN
 ;;^UTILITY(U,$J,358.3,8382,1,4,0)
 ;;=4^99355
 ;;^UTILITY(U,$J,358.3,8383,0)
 ;;=99090^^36^445^2^^^^1
 ;;^UTILITY(U,$J,358.3,8383,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8383,1,2,0)
 ;;=2^COMPUTER DATA ANALYSIS
 ;;^UTILITY(U,$J,358.3,8383,1,4,0)
 ;;=4^99090
 ;;^UTILITY(U,$J,358.3,8384,0)
 ;;=95251^^36^445^3^^^^1
 ;;^UTILITY(U,$J,358.3,8384,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8384,1,2,0)
 ;;=2^CONT GLUCOSE MONITOR,INTERP & RPT
 ;;^UTILITY(U,$J,358.3,8384,1,4,0)
 ;;=4^95251
 ;;^UTILITY(U,$J,358.3,8385,0)
 ;;=95250^^36^445^1^^^^1
 ;;^UTILITY(U,$J,358.3,8385,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8385,1,2,0)
 ;;=2^Amb Cont Glucose Monitor,SQ Sensor;min 72hrs
 ;;^UTILITY(U,$J,358.3,8385,1,4,0)
 ;;=4^95250
 ;;^UTILITY(U,$J,358.3,8386,0)
 ;;=99415^^36^446^1^^^^1
 ;;^UTILITY(U,$J,358.3,8386,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8386,1,2,0)
 ;;=2^Prolonged Clin Staff Svc,1st hr
 ;;^UTILITY(U,$J,358.3,8386,1,4,0)
 ;;=4^99415
 ;;^UTILITY(U,$J,358.3,8387,0)
 ;;=99416^^36^446^2^^^^1
 ;;^UTILITY(U,$J,358.3,8387,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8387,1,2,0)
 ;;=2^Prolonged Clin Staff Svc,Ea Addl 30min
 ;;^UTILITY(U,$J,358.3,8387,1,4,0)
 ;;=4^99416
 ;;^UTILITY(U,$J,358.3,8388,0)
 ;;=11100^^37^447^1^^^^1
 ;;^UTILITY(U,$J,358.3,8388,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,8388,1,1,0)
 ;;=1^11100
 ;;^UTILITY(U,$J,358.3,8388,1,2,0)
 ;;=2^BIOPSY SINGLE SKIN LESION
 ;;^UTILITY(U,$J,358.3,8389,0)
 ;;=43450^^37^447^3^^^^1
 ;;^UTILITY(U,$J,358.3,8389,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,8389,1,1,0)
 ;;=1^43450
 ;;^UTILITY(U,$J,358.3,8389,1,2,0)
 ;;=2^DILATE ESOPHAGUS
 ;;^UTILITY(U,$J,358.3,8390,0)
 ;;=10140^^37^447^4^^^^1
 ;;^UTILITY(U,$J,358.3,8390,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,8390,1,1,0)
 ;;=1^10140
 ;;^UTILITY(U,$J,358.3,8390,1,2,0)
 ;;=2^DRAINAGE OF HEMATOMA/FLUID
